ArticleBioengineering (Basel, Switzerland)2026
Dynamic Pareto Optimization of Consolidated Bioprocessing for Ethanol Titer, Productivity, Conversion, and Operating Severity.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Grey-box modeling framework for consolidated bioprocessing systems: an endpoint-guided approach.Bioresources and bioprocessing · 2026Article
- Observability- and Identifiability-Guided Sensor-Set Design for Digital-Twin-Assisted Consolidated Bioprocessing.Sensors (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Consolidated bioprocessing (CBP), in which enzyme production, substrate hydrolysis, and fermentation occur in a single bioreactor, offers a promising pathway for lignocellulosic ethanol production. However, CBP operation involves competing objectives, including ethanol titer, volumetric productivity, substrate conversion, soluble sugar accumulation, batch duration, control effort, and the operating severity associated with temperature and pH profiles. This study introduces a feasibility-aware multi-objective dynamic optimization framework for identifying Pareto-optimal operating policies for batch CBP. A reduced-order mechanistic model is developed to represent biomass growth, enzyme activity, insoluble substrate hydrolysis, soluble sugar formation and consumption, ethanol production, and inhibition under time-varying temperature and pH conditions. The optimization simultaneously maximizes ethanol titer, productivity, and substrate conversion while minimizing sugar accumulation, operating severity, control movement, and batch time. In the main simulation run, 120,000 dynamic policies were retained for analysis, resulting in 5017 feasible policies and 328 feasible Pareto-optimal policies under a minimum conversion threshold of 0.42. Within the feasible Pareto archive, the highest ethanol titer reached 1.265gL-1, the highest productivity reached 0.017gL-1h-1, and the maximum conversion reached 0.440. Compared with the best criterion-specific static constant-operation baselines, the dynamic Pareto policies improved ethanol titer, productivity, and conversion by 10.6%, 8.3%, and 14.3%, respectively. A feasibility analysis showed that a conversion threshold of 0.42 was stringent but attainable, whereas thresholds of 0.44 and 0.55 were not attainable under the present model and operating bounds. Independent-seed repetitions confirmed a consistent high-performing region across stochastic searches. The resulting Pareto fronts and operating policy maps provide a model-based decision-support basis for selecting dynamic temperature and pH profiles for CBP operation. Because this study is in silico, future experimental validation is required before direct pilot- or industrial-scale application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.